Increasing access to more drugs, Pfizer deepens commitment to health equity

Pfizer’s expansion of its program to include all drugs to which it owns global rights is the latest sign of the pharma’s commitment to health equity, with the addition of more than 470 therapies coming less than a year after it started the program.

Pfizer Inc. (NYSE:PFE) launched “An Accord for a Healthier World” in May 2022, committing to provide all current and future patent-protected medicines and vaccines available in the U.S. or the EU to 45 lower-income countries on a not-for-profit basis. ...